Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,746 | 868 | 99.7% |
| Education | $36.96 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,149 | 322 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,231 | 83 | $0 (2024) |
| Allergan Inc. | $755.61 | 49 | $0 (2019) |
| PFIZER INC. | $612.77 | 48 | $0 (2024) |
| Janssen Biotech, Inc. | $576.28 | 38 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $446.59 | 26 | $0 (2024) |
| QOL Medical, LLC | $440.31 | 24 | $0 (2023) |
| Gilead Sciences, Inc. | $377.61 | 22 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $342.57 | 22 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $306.58 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,387 | 149 | ABBVIE INC. ($671.90) |
| 2023 | $2,275 | 134 | AbbVie Inc. ($946.27) |
| 2022 | $1,832 | 103 | ABBVIE INC. ($1,003) |
| 2021 | $1,526 | 89 | AbbVie Inc. ($769.89) |
| 2020 | $855.17 | 53 | AbbVie Inc. ($409.74) |
| 2019 | $1,576 | 107 | AbbVie, Inc. ($515.53) |
| 2018 | $1,599 | 111 | AbbVie, Inc. ($422.09) |
| 2017 | $1,732 | 124 | Allergan Inc. ($425.01) |
All Payment Transactions
870 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Immunology | ||||||
| 12/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: Immunology | ||||||
| 12/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Immunology | ||||||
| 11/23/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Immunology | ||||||
| 11/16/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Immunology | ||||||
| 11/01/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 752 | 836 | $374,534 | $67,177 |
| 2022 | 16 | 795 | 906 | $562,422 | $67,113 |
| 2021 | 18 | 962 | 1,084 | $598,967 | $80,678 |
| 2020 | 18 | 941 | 1,043 | $478,633 | $64,518 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 61 | 62 | $75,925 | $12,547 | 16.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 56 | 56 | $40,536 | $9,491 | 23.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 48 | 48 | $34,707 | $8,344 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 86 | $18,217 | $6,890 | 37.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 58 | 62 | $45,308 | $6,474 | 14.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 75 | 82 | $47,406 | $5,898 | 12.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $33,842 | $4,146 | 12.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 36 | $7,017 | $3,277 | 46.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $7,404 | $3,183 | 43.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $15,823 | $2,513 | 15.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 28 | $16,940 | $2,116 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,248 | $956.62 | 42.6% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 178 | 193 | $27,917 | $701.67 | 2.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 25 | 35 | $520.00 | $285.84 | 55.0% |
| 80076 | Liver function blood test panel | Office | 2023 | 17 | 20 | $360.00 | $160.20 | 44.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 12 | 15 | $196.00 | $107.26 | 54.7% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 13 | 14 | $168.00 | $88.76 | 52.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 62 | 62 | $75,838 | $11,852 | 15.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 57 | 57 | $40,214 | $10,019 | 24.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 51 | 51 | $36,386 | $8,933 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 72 | 102 | $21,313 | $8,926 | 41.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 50 | 58 | $176,680 | $5,859 | 3.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 64 | 70 | $53,264 | $5,260 | 9.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 49 | 49 | $56,826 | $5,193 | 9.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $22,485 | $3,128 | 13.9% |
About Dr. Brett Thorpe, MD
Dr. Brett Thorpe, MD is a Gastroenterology healthcare provider based in Provo, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962432583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brett Thorpe, MD has received a total of $13,783 in payments from pharmaceutical and medical device companies, with $2,387 received in 2024. These payments were reported across 870 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($13,746).
As a Medicare-enrolled provider, Thorpe has provided services to 3,450 Medicare beneficiaries, totaling 3,869 services with total Medicare billing of $279,486. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Provo, UT
- Active Since 07/03/2006
- Last Updated 11/27/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1962432583
Products in Payments
- LINZESS (Drug) $1,086
- RINVOQ (Biological) $947.01
- Humira (Biological) $876.87
- HUMIRA (Biological) $790.56
- CREON (Drug) $598.97
- ENTYVIO (Biological) $549.30
- XELJANZ (Drug) $526.04
- SKYRIZI (Biological) $484.39
- STELARA (Biological) $428.47
- Entyvio (Biological) $403.54
- ZENPEP (Drug) $368.82
- MAVYRET (Drug) $338.47
- VIBERZI (Drug) $316.10
- GATTEX (Drug) $291.46
- Sucraid (Drug) $287.11
- OCALIVA (Drug) $277.66
- DUPIXENT (Biological) $266.51
- Mavyret (Drug) $245.23
- IBSRELA (Drug) $203.42
- ZEPOSIA (Drug) $181.08
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Provo
Kurt Bodily, Md, MD
Gastroenterology — Payments: $10,960
Thomas Dickinson, Md, MD
Gastroenterology — Payments: $6,132
Brandon Dickinson, M.d, M.D
Gastroenterology — Payments: $5,178
Dr. Clarke Hilbig, M.d, M.D
Gastroenterology — Payments: $3,412
Gregory Craner, Md, MD
Gastroenterology — Payments: $15.13